Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 16, 2020
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
[ Mon, Nov 16th 2020
] - WOPRAI
Fri, November 13, 2020
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
[ Fri, Nov 13th 2020
] - WOPRAI
Ed Arce Maintained (AKRO) at Strong Buy with Increased Target to $64 on, Nov 13th, 2020
Ed Arce of HC Wainwright & Co., Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $62 to $64 on, Nov 13th, 2020.
Ed has made no other calls on AKRO in the last 4 months.
There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $70 on, Thursday, September 10th, 2020
